Workflow
Treatment for Acute Decompensated Heart Failure
icon
搜索文档
Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure
Globenewswire· 2025-04-23 12:00
Initial Clinical Studies Completed with Significant Positive Results The Cleveland Clinic Foundation, Abbott Laboratories and a New Era Associates (NEA) fund to Acquire Economic Interests in VTAK Fort Mill, S.C., April 23, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK:NYSE-American), (the Company) today announced that it has signed a definitive agreement to acquire, through its newly formed, 82% owned subsidiary, Cardionomix, Inc. assets of Cardionomic, Inc. relating to its Cardiac Pulmonary Nerve ...